DiscoverStrategy& InsiderStrategy& Insider Episode 31 - Advancing breakthroughs in rare disease research
Strategy& Insider Episode 31 - Advancing breakthroughs in rare disease research

Strategy& Insider Episode 31 - Advancing breakthroughs in rare disease research

Update: 2025-02-25
Share

Description

Conversation with Matthew Wood, MD, PhD
In this episode, we explore the forefront of rare disease research with Professor Matthew Wood, the Director and Chief Scientific Officer at the Oxford-Harrington Rare Disease Centre (OHC). Professor Wood shares his inspiring journey from his early studies in Cape Town to his impactful career at Oxford University. Learn about the innovative initiatives at OHC and their ambitious plan to bring 40 drugs into clinical trials within the next decade. This episode provides valuable insights into the challenges and opportunities in rare disease treatment, presenting a hopeful vision for rapid diagnosis and effective therapies.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Strategy& Insider Episode 31 - Advancing breakthroughs in rare disease research

Strategy& Insider Episode 31 - Advancing breakthroughs in rare disease research

Thomas Solbach, Ghioia Irritier, Jan-Philipp Loch